Filing Details

Accession Number:
0001104659-24-044296
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-05 16:29:20
Reporting Period:
2024-04-04
Accepted Time:
2024-04-05 16:29:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
727207 Accelerate Diagnostics Inc AXDX Laboratory Analytical Instruments (3826) 841072256
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1938051 Michael Larry Mertz C/O Accelerate Diagnostics, Inc.
3950 S. Country Club Road, Suite 470
Tucson AZ 85714
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-04 2,866 $0.00 55,435 No 4 M Direct
Common Stock Disposition 2024-04-04 978 $0.88 54,457 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Restricted Stock Units Disposition 2024-04-04 2,866 $0.00 2,866 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,298 No 4 M Direct
Footnotes
  1. On April 4, 2022, the reporting person was granted a total of 7,164 restricted stock units ("RSUs"), of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.
  2. The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.